MENU
+Compare
FEMY
Stock ticker: NASDAQ
AS OF
Oct 6, 11:47 AM (EDT)
Price
$0.84
Change
+$0.21 (+33.33%)
Capitalization
27.1M

FEMY Femasys Forecast, Technical & Fundamental Analysis

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more

FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FEMY with price predictions
Oct 03, 2025

Momentum Indicator for FEMY turns positive, indicating new upward trend

FEMY saw its Momentum Indicator move above the 0 level on October 01, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FEMY just turned positive on September 10, 2025. Looking at past instances where FEMY's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

FEMY moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where FEMY advanced for three days, in of 158 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FEMY broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FEMY entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FEMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.986) is normal, around the industry mean (10.969). P/E Ratio (0.000) is within average values for comparable stocks, (54.450). FEMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.741). FEMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (8.278) is also within normal values, averaging (14.774).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FEMY is expected to report earnings to fall 20.81% to -12 cents per share on November 06

Femasys FEMY Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.04
The last earnings report on August 11 showed earnings per share of -15 cents, meeting the estimate of -15 cents. With 12.26M shares outstanding, the current market capitalization sits at 27.10M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
3950 Johns Creek Court
Phone
+1 770 500-3910
Employees
34
Web
https://www.femasys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GWH1.720.19
+12.42%
ESS Tech
AVIR2.900.08
+2.84%
Atea Pharmaceuticals
CSIQ15.20-0.07
-0.46%
Canadian Solar
AMX20.97-0.17
-0.80%
America Movil SAB de CV
ENPH36.80-0.94
-2.49%
Enphase Energy

FEMY and Stocks

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
+51.87%
OFIX - FEMY
30%
Poorly correlated
+2.81%
CSTL - FEMY
30%
Poorly correlated
+2.20%
LUCD - FEMY
30%
Poorly correlated
+1.96%
OM - FEMY
29%
Poorly correlated
+2.84%
GH - FEMY
29%
Poorly correlated
+2.25%
More

Groups containing FEMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
+51.87%
Pharmaceuticals
category (386 stocks)
21%
Poorly correlated
+0.59%
Pharmaceuticals: Other
category (103 stocks)
18%
Poorly correlated
+1.45%